University College London Hospitals (UCLH) NHS Foundation Trust, London, UK.
Institute for Women's Health, University College London (UCL), London, UK.
BJOG. 2023 Jul;130(8):959-967. doi: 10.1111/1471-0528.17476. Epub 2023 Apr 19.
To assess the impact of maternal Coronavirus disease 2019 (COVID-19) infection on placental histopathological findings in an unselected population and evaluate the potential effect on the fetus, including the possibility of vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Retrospective cohort comparative study of placental histopathological findings in patients with COVID-19, compared with controls.
During the COVID-19 pandemic, placentas were studied from women at University College Hospital London who reported and/or tested positive for COVID-19.
Of 10 508 deliveries, 369 (3.5%) women had COVID-19 during pregnancy, with placental histopathology available for 244 women.
Retrospective review of maternal and neonatal characteristics, where placental analysis had been performed. This was compared with available, previously published, histopathological findings from placentas of unselected women.
Frequency of placental histopathological findings and relevant clinical outcomes.
Histological abnormalities were reported in 117 of 244 (47.95%) cases, with the most common diagnosis being ascending maternal genital tract infection. There was no statistically significant difference in the frequency of most abnormalities compared with controls. There were four cases of COVID-19 placentitis (1.52%, 95% CI 0.04%-3.00%) and one possible congenital infection, with placental findings of acute maternal genital tract infection. The rate of fetal vascular malperfusion (FVM), at 4.5%, was higher compared with controls (p = 0.00044).
In most cases, placentas from pregnant women infected with SARS-CoV-2 virus do not show a significantly increased frequency of pathology. Evidence for transplacental transmission of SARS-CoV-2 is lacking from this cohort. There is a need for further study into the association between FVM, infection and diabetes.
在未选择人群中评估母体 2019 年冠状病毒病(COVID-19)感染对胎盘组织病理学发现的影响,并评估其对胎儿的潜在影响,包括严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)垂直传播的可能性。
对伦敦大学学院医院 COVID-19 患者的胎盘组织病理学发现进行回顾性队列比较研究,并与对照组进行比较。
在 COVID-19 大流行期间,研究了在伦敦大学学院医院报告并/或检测出 COVID-19 阳性的孕妇的胎盘。
在 10508 例分娩中,有 369 名(3.5%)孕妇在怀孕期间感染了 COVID-19,其中 244 名孕妇有胎盘组织病理学检查结果。
回顾性分析了有胎盘分析的母亲和新生儿特征,并与以前发表的未选择妇女胎盘组织病理学发现进行了比较。
胎盘组织病理学发现的频率和相关临床结局。
在 244 例中,有 117 例(47.95%)报告了组织学异常,最常见的诊断为上行性母体生殖道感染。与对照组相比,大多数异常的频率无统计学显著差异。COVID-19 胎盘炎有 4 例(1.52%,95%CI 0.04%-3.00%),1 例可能为先天性感染,胎盘发现为急性母体生殖道感染。胎儿血管灌注不良(FVM)的发生率为 4.5%,高于对照组(p=0.00044)。
在大多数情况下,感染 SARS-CoV-2 病毒的孕妇的胎盘未显示出明显增加的病理学发生率。本队列缺乏 SARS-CoV-2 经胎盘传播的证据。需要进一步研究 FVM、感染和糖尿病之间的关联。